SUVRETTA CAPITAL MANAGEMENT, LLC
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 1569064
New York, NY
Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,472,170
-$36,851,551 QoQ
Shares Held
3,680,921
-43.9% QoQ
Ownership
4.82%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#5
of 154 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,923,514,073 across 34 Biotechnology names. FULC ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
4,168,970 | $512,533,171 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,437,000 | $326,098,140 | |
| 3 | LEGN |
Legend Biotech Corp
|
7,070,000 | $204,181,600 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
1,135,406 | $173,512,744 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
4,515,531 | $156,869,546 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $154,516,936 | |
| 7 | BHVN |
Biohaven Ltd.
|
10,286,937 | $153,069,622 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
4,776,423 | $147,257,121 |
All Filings in FULC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,472,170 | 3,680,921 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $13,472,170 | 3,680,921 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,323,721 | 6,561,111 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $74,206,165 | 6,561,111 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $49,505,200 | 5,381,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,970,352 | 5,082,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,594,094 | 5,067,394 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,690,790 | 3,338,466 | Shares | Sole | 2025-02-14 | |
| 2024-12-27 | $16,308,091 | 3,404,612 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $4,222,563 | 1,182,791 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,754,485 | 2,541,046 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,889,707 | 2,848,486 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $37,252,446 | 5,518,881 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,391,831 | 5,718,881 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,872,307 | 5,718,881 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,756,473 | 5,177,710 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,120,565 | 4,274,803 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,541,520 | 3,528,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,442,557 | 3,355,624 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,807,193 | 2,613,412 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $42,023,850 | 2,375,571 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $54,782,945 | 1,941,969 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $17,055,613 | 1,627,444 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,974,925 | 1,525,885 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||